Baidu
map

Stroke:糖尿病患者缺血性卒中风险或无种族差异

2013-05-03 高晓方 译 医学论坛网

  美国一项研究表明,无论种族如何,糖尿病患者在各年龄段仍表现为卒中风险极大升高,并且在<65岁时尤为显著。论文4月25日在线发表于《卒中》(Stroke)。   既往研究显示在糖尿病患者中缺血性卒中发病率在黑人和白人中升高,尤其是那些年龄<55岁的患者。此项基于人群研究对1993~1994、1999和2005年间年龄≥20岁的黑人和白人中的首次缺血性卒中进行了分析。对性别、种族和年

  美国一项研究表明,无论种族如何,糖尿病患者在各年龄段仍表现为卒中风险极大升高,并且在<65岁时尤为显著。论文4月25日在线发表于《卒中》(Stroke)。

  既往研究显示在糖尿病患者中缺血性卒中发病率在黑人和白人中升高,尤其是那些年龄<55岁的患者。此项基于人群研究对1993~1994、1999和2005年间年龄≥20岁的黑人和白人中的首次缺血性卒中进行了分析。对性别、种族和年龄进行适当校正之后计算发病率。

  结果显示,1993~1994、1999和2005年间,首次缺血性卒中患者中糖尿病病史报告率分别为28%、29%和33%。在黑人中,伴和未伴糖尿病者卒中发病率危险比(RR)由1993~1994的5.6降至2005年的3.2;在白人中上述两个时间段的危险比则均保持在3.8不变。然而,RR随年龄不同有所差异;20~65岁患者中观察到风险总体升高5至14倍。

糖尿病相关的拓展阅读:


Diabetes Mellitus: A Risk Factor for Ischemic Stroke in a Large Bi-Racial Population.
BACKGROUND AND PURPOSE
We previously reported increased incidence of ischemic stroke among both blacks and whites with diabetes mellitus, especially in those aged <55 years. With rising prevalence of diabetes mellitus in the past decade, we revisit the impact of diabetes mellitus on stroke incidence in the same population (≈1.3 million) 5 and 10 years later.
METHODS
This is a population-based study. First ischemic strokes among black and white residents of the 5-county Greater Cincinnati/Northern Kentucky region, aged ≥20 years, for periods 7/1993 to 6/1994, 1999, and 2005, were included in this analysis. Incidence rates were adjusted for sex, race, and age, as appropriate, to the 2000 US population.
RESULTS
History of diabetes mellitus among first ischemic strokes was reported for 493/1709 (28%) in 1993/1994, 522/1778 (29%) in 1999, and 544/1680 (33%) in 2005. Risk ratios (95% confidence interval) for rates of stroke in those with versus without diabetes mellitus for blacks reduced significantly from 5.6 in 1993/1994 to 3.2 in 2005; for whites the risk ratio remained stable at 3.8 in 1993/1994 and 2005. However, risk ratios varied with age, with an overall 5- to 14-fold increased risk observed in those aged 20 to 65 years.
CONCLUSIONS
Those with diabetes mellitus remain at greatly increased risk for stroke at all ages, especially <65 years, regardless of race. The rates and risk ratios for 1999 and 2005, although similar to those previously reported for the mid-1990s, take on increased significance, given the epidemic of diabetes mellitus and metabolic syndrome throughout the US and the world.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1892568, encodeId=d6391892568f7, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Jul 17 12:34:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805961, encodeId=88a31805961cd, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Dec 05 05:34:00 CST 2013, time=2013-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281149, encodeId=83c612811494a, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353537, encodeId=6a5a135353e7d, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473699, encodeId=d34514e369980, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1892568, encodeId=d6391892568f7, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Jul 17 12:34:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805961, encodeId=88a31805961cd, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Dec 05 05:34:00 CST 2013, time=2013-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281149, encodeId=83c612811494a, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353537, encodeId=6a5a135353e7d, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473699, encodeId=d34514e369980, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1892568, encodeId=d6391892568f7, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Jul 17 12:34:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805961, encodeId=88a31805961cd, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Dec 05 05:34:00 CST 2013, time=2013-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281149, encodeId=83c612811494a, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353537, encodeId=6a5a135353e7d, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473699, encodeId=d34514e369980, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1892568, encodeId=d6391892568f7, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Jul 17 12:34:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805961, encodeId=88a31805961cd, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Dec 05 05:34:00 CST 2013, time=2013-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281149, encodeId=83c612811494a, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353537, encodeId=6a5a135353e7d, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473699, encodeId=d34514e369980, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1892568, encodeId=d6391892568f7, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Jul 17 12:34:00 CST 2013, time=2013-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805961, encodeId=88a31805961cd, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Thu Dec 05 05:34:00 CST 2013, time=2013-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281149, encodeId=83c612811494a, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353537, encodeId=6a5a135353e7d, content=<a href='/topic/show?id=29e1e4781f1' target=_blank style='color:#2F92EE;'>#种族差异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74781, encryptionId=29e1e4781f1, topicName=种族差异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473699, encodeId=d34514e369980, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sun May 05 06:34:00 CST 2013, time=2013-05-05, status=1, ipAttribution=)]

相关资讯

PLoS Med:先兆子痫是糖尿病发病危险因素

  加拿大一项研究表明,对于无妊娠期糖尿病(GDM)、有先兆子痫(PEC)和(或)妊娠期高血压(GH)的女性,在随访至产后16.5年时,其糖尿病发生风险增加了2倍。与仅有GDM者相比,同时患有GDM、PEC和(或)GH者的糖尿病发生风险显著增加。该论文4月16日在线发表于《公共科学图书馆·医学》(PLoS Med)杂志。   该回顾性研究纳入1994年4月至2008年3月期间在加拿大安

NEJM:糖尿病治疗有进展但仍存不足

  《新英格兰医学杂志》4月25日在线发表的一项研究显示,自1999年以来,成人糖尿病治疗在依从预防措施和控制糖尿病并发症危险因素方面取得了明显进展。然而,仍有半数的患者未达到血糖控制、血压和血脂控制目标,并且半数患者表示未接受过糖尿病教育、常被忽视而未接受推荐的每年1次的疫苗接种、牙科检查和眼部检查(N. Engl. J. Med. 2013;368:16

Diabetes Care:ADA与ENDO低血糖共识

    低血糖对糖尿病患者产生的影响一直以来广受关注,美国糖尿病学会(ADA)和美国内分泌学会(ENDO)对既往与新进证据进行回顾,并于近日公布一份共识文件Hypoglycemia and Diabetes: A Report of aWorkgroup of the American Diabetes Association and The Endocrine Society。  

NEJM:美国糖尿病防治十年进展回顾

  近日发表在《新英格兰医学杂志》(NEJM)上的一项研究表明,1999年-2010年美国糖尿病患者降糖达标率提高了8%,将近12%的患者降压达标,21%的患者LDL胆固醇水平降低。然而33%-49%的患者未能降糖达标,每5例糖尿病患者中就有1例未能戒烟。   研究主要负责人Mohammed Ali医生表示,全美患者对糖尿病的阻击取得了缓慢而有成效的进展。 与糖尿病相关的拓展阅读:

AACE2013:糖尿病治疗方案

  AACE日前公布2013年版《糖尿病综合治疗方案》,方便初级保健医生、内分泌科及其他科室医务工作者更好地预防与治疗糖尿病前期与2型糖尿病。 与糖尿病相关的拓展阅读: Diabetes Care:良好的血糖和血压控制有益于延长糖尿病患者生存期 第一时相胰岛素分泌减少是我国2型糖尿病关键诱因 Diabetic Med:高血压患者治疗时HDL低预示新发糖尿病风险更高 美国糖尿病防

FDA拟重新审议GSK糖尿病药物文迪雅的安全性

     美国联邦卫生顾问小组将于6月份对葛兰素史克旗下糖尿病药物文迪雅(Avandia)的安全性数据予以重新审议,尽管GSK于近日声称,它已不再寻求使之广泛应用于临床。     010年9月份,美国食品药品管理局(FDA)出于对文迪雅心脏病发作和死亡有关的安全性考虑,对该产品的使用设置了严重限制,只允许文迪雅

Baidu
map
Baidu
map
Baidu
map